Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

This study has been terminated.
(study terminated 12Feb09 due to low recruitment)
Princess Margaret Hospital, Canada
Mount Sinai Hospital, Canada
Information provided by:
University Health Network, Toronto Identifier:
First received: April 16, 2007
Last updated: February 12, 2009
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)